Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

X Xie, T Yu, X Li, N Zhang, LJ Foster, C Peng… - Signal transduction and …, 2023 - nature.com
Undruggable proteins are a class of proteins that are often characterized by large, complex
structures or functions that are difficult to interfere with using conventional drug design …

Recent Progress in Modulation of WD40-Repeat Domain 5 Protein (WDR5): Inhibitors and Degraders

R Gurung, D Om, R Pun, S Hyun, D Shin - Cancers, 2023 - mdpi.com
Simple Summary WD40-repeat (WDR) domain proteins play a crucial role in mediating
protein–protein interactions that sustain oncogenesis in human cancers. WDR5 has two …

Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization

MP Schwalm, A Krämer, A Dölle, J Weckesser, X Yu… - Cell chemical …, 2023 - cell.com
The multi-step degradation process of PROteolysis TArgeting Chimeras (PROTACs) poses a
challenge for their rational development, as the rate-limiting steps that determine PROTACs …

Discovery of potent small-molecule inhibitors of WDR5-MYC interaction

J Ding, G Li, H Liu, L Liu, Y Lin, J Gao… - ACS Chemical …, 2023 - ACS Publications
WD repeat domain 5 (WDR5) is a member of the WD40-repeat protein family that plays a
critical role in multiple processes. It is also a prominent target for pharmacological inhibition …

Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5

Y Chen, H Su, J Zhao, Z Na, K Jiang, A Bacchiocchi… - Cell reports, 2023 - cell.com
The conserved WD40-repeat protein WDR5 interacts with multiple proteins both inside and
outside the nucleus. However, it is currently unclear whether and how the distribution of …

Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models

KB Teuscher, S Chowdhury… - Proceedings of the …, 2023 - National Acad Sciences
WD repeat domain 5 (WDR5) is a core scaffolding component of many multiprotein
complexes that perform a variety of critical chromatin-centric processes in the nucleus …

Discovery of potent and selective WDR5 proteolysis targeting chimeras as potential therapeutics for pancreatic cancer

X Yu, D Li, J Kottur, HS Kim, LE Herring… - Journal of Medicinal …, 2023 - ACS Publications
As a core chromatin-regulatory scaffolding protein, WDR5 mediates numerous protein–
protein interactions (PPIs) with other partner oncoproteins. However, small-molecule …

Discovery and structure-based design of inhibitors of the WD repeat-containing protein 5 (WDR5)–MYC interaction

J Ding, L Liu, YL Chiang, M Zhao, H Liu… - Journal of Medicinal …, 2023 - ACS Publications
WDR5 is a critical chromatin cofactor of MYC. WDR5 interacts with MYC through the WBM
pocket and is hypothesized to anchor MYC to chromatin through its WIN site. Blocking the …

Discovery of potent orally bioavailable WD repeat domain 5 (WDR5) inhibitors using a pharmacophore-based optimization

KB Teuscher, KM Meyers, Q Wei, JJ Mills… - Journal of medicinal …, 2022 - ACS Publications
WD repeat domain 5 (WDR5) is a nuclear scaffolding protein that forms many biologically
important multiprotein complexes. The WIN site of WDR5 represents a promising …

WIN site inhibition disrupts a subset of WDR5 function

AJ Siladi, J Wang, AC Florian, LR Thomas… - Scientific Reports, 2022 - nature.com
WDR5 nucleates the assembly of histone-modifying complexes and acts outside this context
in a range of chromatin-centric processes. WDR5 is also a prominent target for …